Analysis of clinical and molecular profiles of patients with innate resistance to ANTI-PD-1 +/- ANTI-CTLA-4 immunotherapy in metastatic melanoma by Gide, T.N., Silva, I.P., Quek, C., Ferguson, P.M., Batten, M., Shang, P., Ahmed, T., Menzies, A.M., Carlino, M.S., Saw, R.P.M., Thompson, J.F., Wilmott, J.S., Scolyer, R.A., Long, G.V.

Get full text

24. Analysis of indoleamine 2,3-dioxygenase expression in longitudinal primary, nodal and distant metastatic melanoma specimens by Gide, T.N., Allanson, B.M., Ferguson, Peter, Menzies, A.M., Saw, R.P.M., Thompson, J.F., Long, G.V., Scolyer, R.A., Wilmott, J.S.

Get full text

Biomarkers of response and resistance to combined anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients utilising multiplex immunofluorescence by Gide, T.N., Quek, C., Madore, J., Menzies, A.M., Dent, R., Carlino, M.S., Guminski, A., Saw, R.P.M., Thompson, J.F., Scolyer, R.A., Long, G.V., Wilmott, J.S.

Get full text